66 related articles for article (PubMed ID: 22863759)
41. Adenovirus-mediated ING4 expression reduces multidrug resistance of human gastric carcinoma cells in vitro and in vivo.
Mao ZL; He SB; Sheng WH; Dong XQ; Yang JC
Oncol Rep; 2013 Nov; 30(5):2187-94. PubMed ID: 23969950
[TBL] [Abstract][Full Text] [Related]
42. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
43. p53 tumor suppressor gene therapy for cancer.
Roth JA; Swisher SG; Meyn RE
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
[TBL] [Abstract][Full Text] [Related]
44. Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications.
Sozzi G; Andriani F; Gramegna M; Roz L
Suppl Tumori; 2002; 1(4):S62. PubMed ID: 12415825
[No Abstract] [Full Text] [Related]
45. Inhibitor of growth-4 is a potential target for cancer therapy.
Yuan S; Jin J; Shi J; Hou Y
Tumour Biol; 2016 Apr; 37(4):4275-9. PubMed ID: 26803518
[TBL] [Abstract][Full Text] [Related]
46. [Mechanism and Prospect of Radiotherapy Combined with Apotatinib
in the Treatment of Non-small Cell Lung Cancer].
Liu G; Wang C; E M
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):847-851. PubMed ID: 29277185
[TBL] [Abstract][Full Text] [Related]
47. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance.
Alhaddad L; Osipov AN; Leonov S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362359
[TBL] [Abstract][Full Text] [Related]
48. Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
Li L; Zhu T; Gao YF; Zheng W; Wang CJ; Xiao L; Huang MS; Yin JY; Zhou HH; Liu ZQ
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27258253
[TBL] [Abstract][Full Text] [Related]
49. Gene Therapy for Lung Cancer.
Lara-Guerra H; Roth JA
Crit Rev Oncog; 2016; 21(1-2):115-24. PubMed ID: 27481008
[TBL] [Abstract][Full Text] [Related]
50. HuntING4 new tumor suppressors.
Kim S
Cell Cycle; 2005 Apr; 4(4):516-7. PubMed ID: 15738650
[TBL] [Abstract][Full Text] [Related]
51. Gene replacement therapy for non-small cell lung cancer: a review.
Roth JA; Grammer SF
Hematol Oncol Clin North Am; 2004 Feb; 18(1):215-29. PubMed ID: 15005290
[TBL] [Abstract][Full Text] [Related]
52. Gene therapy approaches for the management of non-small cell lung cancer.
Roth JA; Grammer SF; Swisher SG; Komaki R; Nemunaitis J; Merritt J; Fujiwara T; Meyn RE
Semin Oncol; 2001 Aug; 28(4 Suppl 14):50-6. PubMed ID: 11605184
[TBL] [Abstract][Full Text] [Related]
53. Gene therapy in lung cancer.
Swisher SG; Roth JA
Curr Oncol Rep; 2000 Jan; 2(1):64-70. PubMed ID: 11122826
[TBL] [Abstract][Full Text] [Related]
54. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
Chaudhary S; Singh A; Kumar P; Kaushik M
J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
[TBL] [Abstract][Full Text] [Related]
55. The role of Bcl-2 family members in non-small cell lung cancer.
Daniel JC; Smythe WR
Semin Thorac Cardiovasc Surg; 2004; 16(1):19-27. PubMed ID: 15366684
[TBL] [Abstract][Full Text] [Related]
56. Gene replacement strategies for lung cancer.
Roth JA
Curr Opin Oncol; 1998 Mar; 10(2):127-32. PubMed ID: 9555535
[TBL] [Abstract][Full Text] [Related]
57. The Pandora's box of novel technologies that may revolutionize lung cancer.
Rad HS; Rad HS; Shiravand Y; Radfar P; Arpon D; Warkiani ME; O'Byrne K; Kulasinghe A
Lung Cancer; 2021 Sep; 159():34-41. PubMed ID: 34304051
[TBL] [Abstract][Full Text] [Related]
58. Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.
Zhou T; Zhang LY; He JZ; Miao ZM; Li YY; Zhang YM; Liu ZW; Zhang SZ; Chen Y; Zhou GC; Liu YQ
Front Immunol; 2023; 14():1133899. PubMed ID: 36865554
[TBL] [Abstract][Full Text] [Related]
59. A Cross-Talk about Radioresistance in Lung Cancer-How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies.
Nowak P; Bil-Lula I; Śliwińska-Mossoń M
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446385
[TBL] [Abstract][Full Text] [Related]
60. Polyene phosphatidylcholine protects against radiation induced tissue injury without affecting radiotherapeutic efficacy in lung cancer.
Zhang H; Jiang T; Yu H; Lu H; Zhao Y; Zhang Y; Fu J; Chen W; Dong P; Zang L; Song H
Am J Cancer Res; 2019; 9(6):1091-1103. PubMed ID: 31285944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
